Cargando…
Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer
OBJECTIVES: To determine the outcome of patients with luminal A, luminal B, human epidermal growth factor receptor-2 (HER-2) positive, and triple negative molecular subtypes of inflammatory breast cancer (IBC) using a retrospective analysis. METHODS: This study was conducted between February 2004 an...
Autores principales: | Zhou, Jingyu, Yan, Yi, Guo, Lei, Ou, Huiying, Hai, Jian, Zhang, Chaojie, Wu, Zhaoyun, Tang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Saudi Medical Journal
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362150/ https://www.ncbi.nlm.nih.gov/pubmed/25399208 |
Ejemplares similares
-
Epithelial–Mesenchymal Transition-Based Gene Signature and Distinct Molecular Subtypes for Predicting Clinical Outcomes in Breast Cancer
por: Hou, Lili, et al.
Publicado: (2022) -
Identification of Distinct Molecular Subtypes of Endometrioid Adenocarcinoma
por: Lei, Jia, et al.
Publicado: (2021) -
Identification of distinct molecular subtypes of uterine carcinosarcoma
por: An, Yang, et al.
Publicado: (2017) -
Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns
por: Guo, Xiangqian, et al.
Publicado: (2018) -
Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment
por: An, Yang, et al.
Publicado: (2017)